A cyotosol-selective nitric oxide bomb as a new paradigm of an anticancer drug. | Chem Commun (Camb);55(98): 14789-14792, 2019 Dec 05. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

A cyotosol-selective nitric oxide bomb as a new paradigm of an anticancer drug.

Park, Dongsik; Im, Sooseok; Saravanakumar, Gurusamy; Lee, Yeong Mi; Kim, Jinhwan; Kim, Kunho; Lee, Junseok; Kim, Jihoon; Kim, Won Jong.

Affiliation

Park D; Department of Chemistry, Pohang University of Science and Technology (POSTECH), Cheongam-ro 77, Nam-gu, Pohang 37673, Republic of Korea. mole@postech.ac.kr wjkim@postech.ac.kr.

Chem Commun (Camb) ; 55(98): 14789-14792, 2019 Dec 05.

Article in En | MEDLINE | ID: mdl-31761922

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytosol / Micelles / Antineoplastic Agents / Nitric Oxide Limits: Animals / Humans Language: En Journal: Chem Commun (Camb) Journal subject: QUIMICA Year: 2019 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytosol / Micelles / Antineoplastic Agents / Nitric Oxide Limits: Animals / Humans Language: En Journal: Chem Commun (Camb) Journal subject: QUIMICA Year: 2019 Document type: Article